medazepam has been researched along with Intellectual Disability in 2 studies
Medazepam: A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viukari, M | 1 |
| Linnoila, M | 1 |
| Pittaluga, G | 1 |
| Mastrangelo, G | 1 |
2 other studies available for medazepam and Intellectual Disability
| Article | Year |
|---|---|
Serum medazepam, diazepam, and N-desmethyldiazepam levels after single and multiple oral doses of medazepam.
Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Chemical Phenomena; Chemistry; Diazepa | 1977 |
[Clinical use of medazepam in neuropsychiatry].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Epilepsy; Female; Humans; Intellectual Disability; Male; Med | 1974 |